Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142163 |
| CAS No | NA |
| Mol.F. | C10H12N2O4 |
| Mol.Wt. | 224.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142164 |
| CAS No | NA |
| Mol.F. | C24H24ClFN6O4 |
| Mol.Wt. | 514.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142165 |
| CAS No | NA |
| Mol.F. | C23H22ClFN6O4 |
| Mol.Wt. | 500.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142166 |
| CAS No | NA |
| Mol.F. | C24H24ClFN6O4 |
| Mol.Wt. | 514.94 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142167 |
| CAS No | NA |
| Mol.F. | C23H22F2N6O4 |
| Mol.Wt. | 484.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142168 |
| CAS No | NA |
| Mol.F. | C25H27F2N9O |
| Mol.Wt. | 507.55 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142169 |
| CAS No | NA |
| Mol.F. | C18H13ClFN5O5 |
| Mol.Wt. | 433.78 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142170 |
| CAS No | NA |
| Mol.F. | C18H15ClFN5O3 |
| Mol.Wt. | 403.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142171 |
| CAS No | NA |
| Mol.F. | C17H19N5O5 |
| Mol.Wt. | 373.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142172 |
| CAS No | NA |
| Mol.F. | C21H20ClFN6O3 |
| Mol.Wt. | 458.88 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142173 |
| CAS No | NA |
| Mol.F. | C27H26ClFN6O8 |
| Mol.Wt. | 616.99 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142174 |
| CAS No | NA |
| Mol.F. | C15H20N4O3S |
| Mol.Wt. | 336.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142175 |
| CAS No | NA |
| Mol.F. | C15H16N2O3 |
| Mol.Wt. | 272.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142176 |
| CAS No | NA |
| Mol.F. | C26H26N2O3 |
| Mol.Wt. | 414.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142177 |
| CAS No | NA |
| Mol.F. | C15H18N2O3 |
| Mol.Wt. | 274.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142178 |
| CAS No | NA |
| Mol.F. | C14H14N2O3 |
| Mol.Wt. | 258.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |